Journals › Sri Lankan Journal of Infectious Diseases
COVID-19 lung lesion treated with pirfenidone and effective rehabilitation: A Case Report
Sri Lankan Journal of Infectious Diseases 12(2) · 2022
https://doi.org/10.4038/sljid.v12i2.8418
Abstract
SARS-CoV-2 leads to an inflammatory and fibrotic state in the lungs which can be the cause of death and even in those who survive cause a functional limitation. A male patient of 28 years with COVID-19 was treated with nitazoxanide 500 mg 6 hourly, ibuprofen 500 mg 8 hourly, levofloxacin 500 mg and vitamin D 4,000 IU 24 hourly, and pirfenidone (K-LP) 1,200 mg 12 hourly. The patient was ventilated and extubated after 13 days in the intensive care unit. He was then immersed in a strict rehabilitation programme based on re-teaching the diaphragmatic respiratory pattern. Pirfenidone at a dose of 1,200 mg twice a day could be considered as a valid option to reduce lung fibrosis caused by the SARS-CoV-2 virus. To ensure optimal recovery, pulmonary rehabilitation therapy should be added to the management.
This index records bibliographic metadata and links to the publisher's own page. It does not host or link directly to full text.